Preview

Systemic Hypertension

Advanced search

"Grey zone" of vasoreactivity during acute vasodilator testing in patients with pulmonary hypertension

Abstract

Aim - to analyze functional status and hemodynamic changes in patients who demonstrate vasoreactivity but doesn’t reach the criteria of "positive respond" ("grey zone") and to compare this data with "responders" and "true non-responders". Material and methods. We enrolled 159 patients with pulmonary hypertension. Right heart catheterization with acute vasodilator testing was performed in all cases. Depending on hemodynamic respond during acute vasoreactivity testing patients were divided in to three groups: "responders", "true non-responders" and patients in the "grey zone". The following parameters were analyzed in all included patients: basic clinical parameters, hemodynamic changes, right ventricle size, right atrium area, 6-minute walking test distance and time to clinical worsening. Results. In our study it was shown that patients of "grey zone" had several clinical and hemodynamic parameters that differ significantly from patients "responders" and "true non-responders". Patients in the "grey zone" also have the longest time to clinical worsening.

About the Authors

O. V. Sagaydak
A.L.Myasnikov Institute of Clinical Cardiology Russian Cardiological Scientific-Industrial Complex of the Ministry of Health of the Russian Federation
Russian Federation


N. M. Danilov
A.L.Myasnikov Institute of Clinical Cardiology Russian Cardiological Scientific-Industrial Complex of the Ministry of Health of the Russian Federation
Russian Federation


Yu. G. Matchin
A.L.Myasnikov Institute of Clinical Cardiology Russian Cardiological Scientific-Industrial Complex of the Ministry of Health of the Russian Federation
Russian Federation


T. V. Martynyuk
A.L.Myasnikov Institute of Clinical Cardiology Russian Cardiological Scientific-Industrial Complex of the Ministry of Health of the Russian Federation
Russian Federation


I. E. Chazova
A.L.Myasnikov Institute of Clinical Cardiology Russian Cardiological Scientific-Industrial Complex of the Ministry of Health of the Russian Federation
Russian Federation


References

1. Galie N, Humbert M, Vachieryc J, Gibbs S et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 2016; 37: 67-19; doi:10.1093/eurheartj/ehv317

2. Langleben D, Stylianos E. Orfanos, Giovinazzo M. Acute Vasodilator Responsiveness and Microvascular Recruitment in Idiopathic Pulmonary Arterial Hypertension. Ann Intern Med 2015; 162 (2): 154-; doi:10.7326/M14-1402

3. Galiи N, Torbicki A, Barst R et al. Task Force. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J 2004; 25: 2243-78.

4. Tonelli A.R, Alnuaimat H, Mubarak K. Pulmonary vasodilator testing and use of calcium channel blockers in pulmonary arterial hypertension. Respiratory Medicine 2010; 104: 481e496.

5. Halliday S.J, Hemnes A.R, Robbins I.M et al. Prognostic value of acute vasodilator response in pulmonary arterial hypertension: Beyond the "classic" responders. J Heart Lung Transplant 2015; 34 (3): 312-8.

6. Sitbon O, Humbert M, Jais X et al. Long - term response to calcium channel blockers in idiopathic pulmonary arterial hypertension. Circulation 2005; 111: 3105-11.


Review

For citations:


Sagaydak O.V., Danilov N.M., Matchin Yu.G., Martynyuk T.V., Chazova I.E. "Grey zone" of vasoreactivity during acute vasodilator testing in patients with pulmonary hypertension. Systemic Hypertension. 2016;13(2):73-76. (In Russ.)

Views: 136


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2075-082X (Print)
ISSN 2542-2189 (Online)